Edmonton, Canada

Ou Ligong

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aicuris Gmbh + Co. Kg.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ou Ligong. Retrieved from https://idiyas.com/inventor/ou-ligong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



 

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ou Ligong

Introduction

Ou Ligong is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of antibacterial agents through his innovative work on novel compounds. With a total of 2 patents, his research focuses on the development of effective antimicrobial solutions.

Latest Patents

Ou Ligong's latest patents include the invention of amidine substituted β-lactam compounds. These compounds are particularly useful as antibacterial agents. The present invention relates to the preparation and use of these novel β-lactam compounds, which are amidine substituted monobactam derivatives. This innovation aims to enhance the effectiveness of antimicrobial agents in combating bacterial infections.

Career Highlights

Ou Ligong is currently associated with Aicuris GmbH & Co. KG, where he continues to advance his research in the field of antimicrobial agents. His work has garnered attention for its potential impact on public health and the treatment of bacterial infections.

Collaborations

Throughout his career, Ou Ligong has collaborated with esteemed colleagues such as Burkhard Klenke and Irith Wiegand. These partnerships have contributed to the success of his research and the development of innovative solutions in the field.

Conclusion

Ou Ligong's contributions to the field of antibacterial agents through his innovative patents highlight his dedication to improving public health. His work continues to pave the way for advancements in antimicrobial treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…